Atlas FDA

Solesta Injectable Gel

FDA premarket approval P100014/S022 · decided 2019-08-29

Approval details

PMA number
P100014
Supplement
S022
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Solesta Injectable Gel
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Palette Life Sciences
Date received
2019-08-16
Decision date
2019-08-29
Days to decision
13 days
Decision code
OK30
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Santa Barbara, CA
Statement
Replacement of a wall section with a door in the 3:125B clean room at the Q-Med manufacturing site.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Barrigel Injectable Gel (K220641)Palette Life Sciences2022-05-26